Monday, June 01, 2020 11:17:29 AM
AGN will need to have all the ducks in nice rows. S Korea appears to be silent which I expected. AGN is not a sponsor on this trial from what Dr Moreau said in the past. This is a Korean led investigational study, right?
Seems like it is vogue now to claim even mild results as great. The NDMA/ Sr1 antagonist angle is AGN's. Others have documented the science. I have bought my share and will await news from the several paths worldwide where experienced other scientists are taking seriously the possibilities of Ifenprodil presented by AGN and supporting Phase2/2b to 3 Clinical trials. Korea might be fully in process.
AGN has set up Trials for CC/IPF and now COVID and is producing the intravenous form of Ifenprodil along with having the 20mg pill form.
Not bad for a $2 bit bet, I'll let my money ride without genuflecting contortions to other's...GLTA...
BTW, 7 days to NOVOTECH Asia clinical trials update forum.
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM